Whitehawk Therapeutics (WHWK) Research & Development (2016 - 2026)
Whitehawk Therapeutics (WHWK) posted Research & Development of $12.89 million for Q2 2026, down 73.6% from $48.81 million a year earlier and down 25.2% from the prior quarter.
Powered by 
Analysis
Whitehawk Therapeutics (WHWK) Research & Development (2016 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Whitehawk Therapeutics was $63.49 million, down 22.5% year-over-year; for FY2025, it came in at $90.96 million, up 78.3% from FY2024.
- Annual Research & Development has increased for six consecutive years, with a five-year compound annual growth rate of 43.4% (FY2020 to FY2025).
- In prior years, Whitehawk Therapeutics' Research & Development was $51.03 million in FY2024 (+4.3%), $48.93 million in FY2023 (+49.8%), $32.66 million in FY2022 (+66.0%) and $19.67 million in FY2021 (+31.1%).
- The Q2 2026 figure stands as the lowest quarterly Research & Development since Q1 2025.
- On a year-over-year basis, Research & Development increased in five of the last eight quarters, with growth averaging 41.6%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q2 2025, with growth of 272.8%; the weakest was Q2 2026, with a decline of 73.6%.
- According to Business Quant data, Research & Development for the three prior quarters was $17.23 million (Q1 2026), $19.02 million (Q4 2025) and $14.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,160.65 Bn | 1,129.23 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 633.19 Bn | 551.72 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.90 Bn | 475.01 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 377.07 Bn | 331.45 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 302.35 Bn | 266.34 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 240.68 Bn | 196.07 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 193.20 Bn | 167.40 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Whitehawk Therapeutics | 271.95 Mn | 81.95 Mn | - | 12.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.89 Mn |
| Mar 31, 2026 | 17.23 Mn |
| Dec 31, 2025 | 19.02 Mn |
| Sep 30, 2025 | 14.35 Mn |
| Jun 30, 2025 | 48.81 Mn |
| Mar 31, 2025 | 8.79 Mn |
| Dec 31, 2024 | 14.35 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 13.09 Mn |
| Mar 31, 2024 | 13.59 Mn |
| Dec 31, 2023 | 12.77 Mn |
| Sep 30, 2023 | 11.89 Mn |
| Jun 30, 2023 | 13.32 Mn |
| Mar 31, 2023 | 10.96 Mn |
| Dec 31, 2022 | 9.37 Mn |
| Sep 30, 2022 | 8.77 Mn |
| Jun 30, 2022 | 7.73 Mn |
| Mar 31, 2022 | 6.79 Mn |
| Dec 31, 2021 | 7.23 Mn |
| Sep 30, 2021 | 5.75 Mn |
API Access
Whitehawk Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=WHWK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "WHWK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=WHWK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();